Cargando…

Author Correction: Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies

Detalles Bibliográficos
Autores principales: Lewis, Alexander C., Wallington-Beddoe, Craig T., Powell, Jason A., Pitson, Stuart M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257673/
https://www.ncbi.nlm.nih.gov/pubmed/34226526
http://dx.doi.org/10.1038/s41420-020-00380-1
_version_ 1783718361145802752
author Lewis, Alexander C.
Wallington-Beddoe, Craig T.
Powell, Jason A.
Pitson, Stuart M.
author_facet Lewis, Alexander C.
Wallington-Beddoe, Craig T.
Powell, Jason A.
Pitson, Stuart M.
author_sort Lewis, Alexander C.
collection PubMed
description
format Online
Article
Text
id pubmed-8257673
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82576732021-07-23 Author Correction: Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies Lewis, Alexander C. Wallington-Beddoe, Craig T. Powell, Jason A. Pitson, Stuart M. Cell Death Discov Correction Nature Publishing Group UK 2021-06-18 /pmc/articles/PMC8257673/ /pubmed/34226526 http://dx.doi.org/10.1038/s41420-020-00380-1 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Lewis, Alexander C.
Wallington-Beddoe, Craig T.
Powell, Jason A.
Pitson, Stuart M.
Author Correction: Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies
title Author Correction: Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies
title_full Author Correction: Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies
title_fullStr Author Correction: Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies
title_full_unstemmed Author Correction: Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies
title_short Author Correction: Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies
title_sort author correction: targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257673/
https://www.ncbi.nlm.nih.gov/pubmed/34226526
http://dx.doi.org/10.1038/s41420-020-00380-1
work_keys_str_mv AT lewisalexanderc authorcorrectiontargetingsphingolipidmetabolismasanapproachforcombinationtherapiesinhaematologicalmalignancies
AT wallingtonbeddoecraigt authorcorrectiontargetingsphingolipidmetabolismasanapproachforcombinationtherapiesinhaematologicalmalignancies
AT powelljasona authorcorrectiontargetingsphingolipidmetabolismasanapproachforcombinationtherapiesinhaematologicalmalignancies
AT pitsonstuartm authorcorrectiontargetingsphingolipidmetabolismasanapproachforcombinationtherapiesinhaematologicalmalignancies